
GenBio AIrevenue
Drug Discovery SoftwarePalo Alto, CaliforniaFounded 2024CEO Fred Hu
GenBio.AI, Inc. (GenBio AI) is an innovative global startup dedicated to developing the world's first AI-driven Digital Organism, an integrated system of multiscale foundation models for predicting, simulating, and programming biology at all levels.
GenBio AI revenue
GenBio AI has not published its revenue. GetLatka estimates it at about $4.5M a year (November 2025).
| As of | Revenue | Source |
|---|---|---|
| Nov 2025 | $4.5MEST | GetLatka estimate |
GenBio AI competitors
GenBio AI competes most directly with Xaira Therapeutics, Cradle and Recursion.
| Company | Revenue | Funding | Employees | Founded |
|---|---|---|---|---|
| $20.2M | $1B | 182 | 2023 | |
| $5M | $29.9M | 57 | 2021 | |
| $4.5M | – | 41 | 2024 | |
| – | – | 98 | 2025 |
GenBio AI CEO, founders & employees
Fred Hu founded GenBio AI in 2024 and runs it as CEO. GenBio AI has 41 employees (November 2025, LinkedIn).
- Fred HuCEO/Founder
GenBio AI FAQ
What is GenBio AI's revenue?
GetLatka estimates GenBio AI's revenue at about $4.5M a year (November 2025). The company hasn't published its own figure.
How many employees does GenBio AI have?
GenBio AI has 41 employees as of November 2025, according to LinkedIn.
Who is the CEO of GenBio AI?
Fred Hu is the CEO of GenBio AI and founded the company in 2024.
Who founded GenBio AI?
Fred Hu founded GenBio AI in 2024.
Browse Drug Discovery Software
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Oct 7, 2026Data disclaimerReport a correctionClaim this profileRun GenBio AI? Join the podcast